Fox Chase Cancer Center CEO Chosen National President of the American Cancer Society
PHILADELPHIA (November 1, 2001) - Fox Chase Cancer Center president and CEO Robert C Young, MD, has been chosen to serve as national president of the American Cancer Society (ACS), the nation's leading voluntary health agency devoted to fighting cancer. He is the first Philadelphian in 25 years to lead the organization. President-elect Young, a Chestnut Hill resident, will receive the official nod on Nov. 3rd at the ACS annual meeting in Anaheim, California.
Young has been an active member in the ACS at the local, state, and national levels for more than 12 years. In addition to serving as president, he is a member of the ACS national Board of Directors.
Young has been president of Fox Chase Cancer Center for 14 years. Internationally known for his work in the treatment of lymphoma and ovarian cancer, Young serves on the Board of Scientific Advisors of the National Cancer Institute. He is past president of the American Society of Clinical Oncology, one of the world's largest oncology societies, and is past president of the International Gynecologic Cancer Society. Most recently, Young served as chairman of the board of the National Comprehensive Cancer Network, a nationwide alliance of leading academic cancer centers dedicated to insuring the highest-quality, cost-effective cancer care.
"I come to this position from the perspective of a lifelong cancer researcher," said Young, one of the first ACS presidents to also lead a major cancer research center. "One of the most important challenges before the Society is to continue to find the correct balance between public health efforts of the ACS and the need for cancer research which ultimately supplements this strategy. I think I bring a fresh perspective to this effort and I hope to excite the public."
During his one-year tenure, Dr. Young will remain president of Fox Chase Cancer Center an institution which has experienced tremendous growth over the past decade.
"The ACS presidency is a great challenge, but one which Dr. Young is more than prepared to meet," said Philip Lippincott, chairman of the Fox Chase Cancer Center Board of Directors. "The Fox Chase Board and staff of Fox Chase Cancer would like to congratulate him on his election, express our full support and our confidence that he will bring the same energy, passion and vision to the ACS that mark his presidency at Fox Chase. We wish him and the American Cancer Society a productive and positive year."
Born in Columbus, Ohio, Young received his BSc degree in zoology in 1960 from Ohio State University and his MD in 1965 from Cornell University Medical College. He is board-certified in internal medicine, hematology and oncology by the American Board of Internal Medicine.
Young came to Fox Chase in 1988 from the National Cancer Institute, where he was associate director of the centers and community oncology program. He also served as chief of its medicine branch for 14 years.
The American Cancer Society is the nationwide community-based voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives and diminishing suffering from cancer, through research, education, advocacy and service. For information about cancer call 800-ACS-2345 or visit the American Cancer Society's website.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site or call 1-888-FOX CHASE
The Electronic Press Kit is designed to provide the media with information regarding Dr. Young and the American Cancer Society. For further information, or to schedule an interview, please contact Karen Carter Mallet, director of Public Affairs at Fox Chase Cancer Center, at 215-728-2700.
Fox Chase Cancer Center, part of Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase also was among the first institutions to receive the National Cancer Institute’s prestigious comprehensive cancer center designation in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are routinely recognized in national rankings, and the Center’s nursing program has achieved Magnet status for excellence three consecutive times. Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research and oversees programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX-CHASE (1-888-369-2427).